Prescription drug · BLA
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 NDC 73070-200
insulin aspart · Insulin aspart 100 [iU]/mL · Injection, Suspension · Subcutaneous · Novo Nordisk Pharma, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 73070-200-11 | 73070020011 | 1 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASSMarketed from Sep 10, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Insulin Aspart Protamine and Insulin Aspart Mix 70/30Suffix: Mix 70/30
- Generic name (nonproprietary)
- insulin aspart
- Active ingredients
- Insulin aspart — 100 [iU]/mL
- Dosage form
- Injection, Suspension
- Route
- Subcutaneous
- Labeler
- Novo Nordisk Pharma, Inc.
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 021172
- Marketing start
- Marketing end
- Other FDA classes
- Insulin (Chemical structure)
- Identifiers
- Product ID 73070-200_885b9016-188e-469d-926d-ae8019b69612SPL ID 885b9016-188e-469d-926d-ae8019b69612SPL set ID fc94baa4-3606-48bc-a781-9617ab6960efRxCUI 351297, 847191UNII D933668QVXUPC 0373070200114
- Pharmacologic class
- Insulin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N473070020011followed by a unit qualifier and the quantityPackage 73070-0200-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: • Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is not recommended for the treatment of diabetic ketoacidosis. • The proportions of rapid-acting and long-acting insulins in Insulin Aspart Protamine and Insulin Aspart Mix 70/30 are fixed and do not allow for basal versus prandial dose adjustments. Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is a mixture of insulin aspart protamine, an intermediate-acting human insulin analog, and insulin aspart, a rapid-acting huma…
Excerpt only. Read the full label for complete information.
Other NDCs under BLA 021172
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharma, Inc. | 73070-203 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-2119 |
| Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-3236 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk | 0169-3685 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk | 0169-3696 |
| .Insulin Aspart Protamine and Insulin Aspartinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-4959 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk | 0169-2200 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk | 0169-2201 |
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.